StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$50.62+2.40 (+4.98%)

Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –

Prestige Consumer Healthcare pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Prestige Consumer Healthcare's pe ratio was 12.4× on Nov 11, 2026, against 14.8× a year earlier. Over the last 5 years it ranged from 10.8× to 20.6×, with a median of 15.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.4×−2.9
2025Dec 31, 202515.3×−3.7
2024Dec 31, 202419.0×+4.2
2023Apr 28, 202314.8×−0.4
2022Dec 30, 202215.2×−1.9
2021Dec 31, 202117.1×+6.3
2020Dec 31, 202010.8×−13.3
2019Apr 30, 201924.1×+19.3
2018Dec 31, 20184.8×−17.4
2017Dec 29, 201722.2×−18.2
2016Dec 30, 201640.4×+13.9
2015Dec 31, 201526.5×−8.5
2014Dec 31, 201435.1×+13.2
2013Dec 31, 201321.8×−1.5
2012Dec 31, 201223.3×+7.6
2011Dec 30, 201115.7×−3.0
2010Dec 31, 201018.7×–

More Prestige Consumer Healthcare figures

See a number that looks wrong?